0001209191-15-000974.txt : 20150105 0001209191-15-000974.hdr.sgml : 20150105 20150105162924 ACCESSION NUMBER: 0001209191-15-000974 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150105 DATE AS OF CHANGE: 20150105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 15505280 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-31 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2014-12-31 4 M 0 4800 10.41 A 343695 D Common Stock 2014-12-31 4 M 0 1300 17.16 A 344995 D Common Stock 2014-12-31 4 M 0 4400 35.64 A 349395 D Common Stock 2014-12-31 4 S 0 2000 119.32 D 347395 D Common Stock 2014-12-31 4 S 0 4900 120.38 D 342495 D Common Stock 2014-12-31 4 S 0 3200 121.10 D 339295 D Common Stock 2014-12-31 4 S 0 400 121.80 D 338895 D Common Stock 13286 I 401(k) Common Stock 172589 I Common Stock held in trust Stock Option (right to buy) 10.41 2014-12-31 4 M 0 4800 0.00 D 2015-02-02 Common Stock 4800 19388 D Stock Option (right to buy) 17.16 2014-12-31 4 M 0 1300 0.00 D 2015-07-19 Common Stock 1300 36900 D Stock Option (right to buy) 35.64 2014-12-31 4 M 0 4400 0.00 D 2016-02-01 Common Stock 4400 547200 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $119.32 (range $118.78 to $119.69). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $120.38 (range $119.78 to $120.77). Open market sales reported on this line occurred at a weighted average price of $121.10 (range $120.79 to $121.43). Open market sales reported on this line occurred at a weighted average price of $121.80 (range $121.79 to $121.80). Common stock held in grantor retained annuity trusts. Fully vested. Kenneth L. Horton, Attorney-In-Fact 2015-01-05